Research / CBT / Fundamental state Inspectable configuration
State dimensions Filing 0001564590-22-028483 General Corporate
Debt relative to revenue 42th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.debt_to_revenue
122.72% · OPTIONAL · VALID
Capex intensity 16th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.capex_revenue_ratio
4.35% · OPTIONAL · VALID
Operating cash generation 21th Own-history percentile · N=19
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
2.96% · OPTIONAL · VALID
Revenue growth 73th Own-history percentile · N=15
Evidence method Yoy · gp.fundamentals.revenue
25.30% · CORE · VALID
Inventory pressure 53th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
57.79% · OPTIONAL · VALID
Gross margin 26th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.gross_margin
20.45% · CORE · VALID
Operating margin 84th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.operating_margin
14.62% · CORE · VALID
R&D intensity 0th Own-history percentile · N=19
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.22% · OPTIONAL · VALID
SBC intensity 47th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.52% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 36 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 122.44%
Current 122.72%
Delta 0.28% Capex Intensity Increased
Previous 3.75%
Current 4.35%
Delta 0.60% Cash Generation Increased
Previous 0.92%
Current 2.96%
Delta 2.04% Growth Decreased
Previous 29.69%
Current 25.30%
Delta -4.39% Inventory Pressure Decreased
Previous 57.97%
Current 57.79%
Delta -0.18% Margin Decreased
Previous 21.25%
Current 20.45%
Delta -0.79% Profitability Decreased
Previous 14.74%
Current 14.62%
Delta -0.12% R And D Intensity Decreased
Previous 1.28%
Current 1.22%
Delta -0.06% Sbc Intensity Increased
Previous 0.46%
Current 0.52%
Delta 0.06% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.